These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10323318)

  • 1. Parkinsonism, pyramidal signs, polyneuropathy, and cognitive decline after long-term occupational solvent exposure.
    Hageman G; van der Hoek J; van Hout M; van der Laan G; Steur EJ; de Bruin W; Herholz K
    J Neurol; 1999 Mar; 246(3):198-206. PubMed ID: 10323318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Parkinsonism induced by solvent abuse.
    Uitti RJ; Snow BJ; Shinotoh H; Vingerhoets FJ; Hayward M; Hashimoto S; Richmond J; Markey SP; Markey CJ; Calne DB
    Ann Neurol; 1994 May; 35(5):616-9. PubMed ID: 8179306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease and solvents: Is there a causal link?
    Reis J; Benbrick E; Bonneterre V; Spencer PS
    Rev Neurol (Paris); 2016 Dec; 172(12):761-765. PubMed ID: 27838093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine transporter density is decreased in parkinsonian patients with a history of manganese exposure: what does it mean?
    Kim Y; Kim JM; Kim JW; Yoo CI; Lee CR; Lee JH; Kim HK; Yang SO; Chung HK; Lee DS; Jeon B
    Mov Disord; 2002 May; 17(3):568-75. PubMed ID: 12112209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine transporter binding study in differentiating carbon disulfide induced parkinsonism from idiopathic parkinsonism.
    Huang CC; Yen TC; Shih TS; Chang HY; Chu NS
    Neurotoxicology; 2004 Mar; 25(3):341-7. PubMed ID: 15019297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive parkinsonism in a young experimental physicist following long-term exposure to methanol.
    Finkelstein Y; Vardi J
    Neurotoxicology; 2002 Oct; 23(4-5):521-5. PubMed ID: 12428724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological deficits in solvent-exposed painters: a syndrome including impaired colour vision, cognitive defects, tremor and loss of vibration sensation.
    Dick F; Semple S; Chen R; Seaton A
    QJM; 2000 Oct; 93(10):655-61. PubMed ID: 11029475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progression after chronic manganese exposure.
    Huang CC; Lu CS; Chu NS; Hochberg F; Lilienfeld D; Olanow W; Calne DB
    Neurology; 1993 Aug; 43(8):1479-83. PubMed ID: 8351000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of postural reflexes in long-term occupational solvent exposure.
    Kuriwaka R; Mitsui T; Fujiwara S; Nishida Y; Matsumoto T
    Eur Neurol; 2002; 47(2):85-7. PubMed ID: 11844896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ototoxicity effects of low exposure to solvent mixture among paint manufacturing workers.
    Juárez-Pérez CA; Torres-Valenzuela A; Haro-García LC; Borja-Aburto VH; Aguilar-Madrid G
    Int J Audiol; 2014 Jun; 53(6):370-6. PubMed ID: 24684406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solvent exposure and cognitive function in automotive technicians.
    Bates MN; Reed BR; Liu S; Eisen EA; Hammond SK
    Neurotoxicology; 2016 Dec; 57():22-30. PubMed ID: 27545874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurophysiological and psychological disorders and occupational exposure to organic solvents.
    Grasso P; Sharratt M; Davies DM; Irvine D
    Food Chem Toxicol; 1984 Oct; 22(10):819-52. PubMed ID: 6541621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinsonism due to n-hexane exposure.
    Pezzoli G; Barbieri S; Ferrante C; Zecchinelli A; Foà V
    Lancet; 1989 Oct; 2(8667):874. PubMed ID: 2571809
    [No Abstract]   [Full Text] [Related]  

  • 14. Occupational and environmental causes of parkinsonism.
    Tanner CM
    Occup Med; 1992; 7(3):503-13. PubMed ID: 1496432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver function tests and urinary albumin in house painters with previous heavy exposure to organic solvents.
    Lundberg I; Nise G; Hedenborg G; Högberg M; Vesterberg O
    Occup Environ Med; 1994 May; 51(5):347-53. PubMed ID: 8199687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic solvent exposure, genes, and risk of neuropsychological impairment.
    Dick F; Semple S; Osborne A; Soutar A; Seaton A; Cherrie JW; Walker LG; Haites N
    QJM; 2002 Jun; 95(6):379-87. PubMed ID: 12037246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A screening programme on chronic solvent-induced encephalopathy among Dutch painters.
    Spee T; van Valen E; van Duivenbooden C; van der Laan G
    Neurotoxicology; 2012 Aug; 33(4):727-33. PubMed ID: 22664100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurobehavioral effects of long-term occupational exposure to organic solvents: two comparable studies.
    Spurgeon A; Gray CN; Sims J; Calvert I; Levy LS; Harvey PG; Harrington JM
    Am J Ind Med; 1992; 22(3):325-35. PubMed ID: 1519617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffuse white matter lesions in carbon disulfide intoxication: microangiopathy or demyelination.
    Ku MC; Huang CC; Kuo HC; Yen TC; Chen CJ; Shih TS; Chang HY
    Eur Neurol; 2003; 50(4):220-4. PubMed ID: 14634266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Major neurological disease and occupational exposure to organic solvents.
    Seaton A; Jellinek EH; Kennedy P
    Q J Med; 1992 Sep; 84(305):707-12. PubMed ID: 1480744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.